Dethroning E. coli?

Some scientists hope to replace microbiology’s workhorse bacterium with fast-growing Vibrio natriegens.

Written byAlison F. Takemura
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Vibrio cholerae, congener to V. natriegensWIKIMEDIA, MICRORAO Escherichia coli has served science well. But it takes 20 minutes to reproduce. So some scientists have suggested an alternative: the salt marsh-dwelling bacterium Vibrio natriegens, which—under optimal conditions—reproduces in half that time.

Harvard geneticists George Church and Henry Lee and colleagues have developed genetic tools to make the nonpathogenic V. natriegens into a model system. The team reported its results earlier this month (June 12) a bioRxiv preprint. The researchers sequenced and annotated the V. natriegens genome and honed methods to disrupt the bacterium’s genes with transposons and edit its DNA using CRISPR.

“We want to develop tools that would make it a drop in, turn-key alternative for E. coli,” Lee told Science.

Biologist Adam Arkin of the University of California, Berkeley, who was not involved in the work, remains skeptical that V. natriegens can replace the lab standby. “Over the course of a hundred years of intense study, we have a huge amount of information about ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies